home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over ↗

December 12, 2024

Via The Motley Fool

Topics Stocks

Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory? ↗

December 11, 2024

Super Micro faces potential delisting from Nasdaq 100 Index due to underperformance and auditing scandal. Uncertainty surrounds its future.

Via Benzinga

Unpacking the Latest Options Trading Trends in Moderna ↗

December 10, 2024

Via Benzinga

Expert Outlook: Moderna Through The Eyes Of 19 Analysts ↗

December 10, 2024

Via Benzinga

Large-Cap Stocks In Trouble - Sunday, Dec. 8 ↗

December 08, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Topics Stocks / Equities

Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today ↗

November 25, 2024

Via Benzinga

Moderna to Present at Upcoming Conferences in December 2024

November 25, 2024

Via ACCESSWIRE

Looking Into Moderna's Recent Short Interest ↗

November 22, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Moderna ↗

November 19, 2024

Via Benzinga

Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024? ↗

December 05, 2024

Via The Motley Fool

Topics Stocks

Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗

December 01, 2024

Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP.

Via Benzinga

10 Worst Performing Large-Caps Last 12 Months ↗

November 28, 2024

Over the past twelve months ten Large-Cap stocks have underperformed all others.

Via Talk Markets

Topics Stocks / Equities

Bird Flu Found In Raw Milk Leads To Recall In California ↗

November 26, 2024

Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health.

Via Benzinga

Topics Product Recall

Demystifying Moderna: Insights From 16 Analyst Reviews ↗

November 15, 2024

Via Benzinga

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over ↗

November 26, 2024

Via The Motley Fool

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday ↗

November 25, 2024

Via Benzinga

Large-Cap Stocks In Trouble - Saturday, Nov. 23 ↗

November 23, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Topics Stocks / Equities

Is Biotech’s Bull Run Over? Examining Election Impacts

November 21, 2024

The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.

Via MarketBeat

Topics ETFs Government

Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines? ↗

November 20, 2024

According to the Los Angeles Times, the total bird flue case count in the U.S. stands at 54; 31 cases are attributed to the dairy industry.

Via Benzinga

Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination ↗

November 18, 2024

Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.

Via Benzinga

Tech, Tesla Helping Wall Street Higher ↗

November 18, 2024

Stocks are starting the final full week of November off strong.

Via Talk Markets

Topics Stocks / Equities

Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone ↗

November 18, 2024

Via Benzinga

Topics Stocks

Large-Cap Stocks In Trouble - Sunday, Nov. 17 ↗

November 17, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers ↗

November 17, 2024

10 worst performing large-cap stocks last week: MPWR, SMCI, MRNA, LDOS, MNDY, PCVX, BAH, ABBV, CACI, XPEV. Check if they're in your portfolio.

Via Benzinga

Deciphering Disruption: Inside Cathie Wood's Latest Plays

November 16, 2024

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

Via MarketBeat

Topics Artificial Intelligence ETFs

Moderna Shares Are Dipping Today: What's Going On? ↗

November 15, 2024

Shares of Moderna Inc. (NASDAQ: MRNA) are trading lower after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS). Here's what you...

Via Benzinga

Topics Government

Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth ↗

November 15, 2024

To gain an edge, this is what you need to know today.

Via Benzinga

European And US Vaccine Stocks Are Under Pressure - Here's WHy ↗

November 15, 2024

Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.

Via Benzinga

Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS ↗

November 15, 2024

President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Via Investor's Business Daily

Topics Government

WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill ↗

November 15, 2024

Trump's decision to appoint Kennedy, known for his vaccine skepticism, has sparked significant attention.

Via Benzinga

Topics Government

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com